Maryland IDEA Disputes
{stats.marylandIdeaDisputes}/10K
vs National Average: 32.4
ADA Employment Charges
{stats.adaCharges.toLocaleString()}
33% of all EEOC charges
HIPAA Genetic Breaches
{stats.hipaaBreaches}
+35% annual growth
GINA Enforcement
{stats.ginaCharges}
+35% YoY growth
| Case ID | Type | Status | Description |
|---|---|---|---|
| {caseItem.id} | {caseItem.type} | {caseItem.status} | {caseItem.description} |
Due process complaints increased 78.5% over 11 years. Maryland rate (72.6 events/10K) is 2.24x national average (32.4). Settlements represent ~60% of resolved cases with growing parent advocacy and IEP dispute complexity.
~29,000 ADA charges annually (33% of all EEOC charges). Retaliation charges represent ~50% of all EEOC charges. 5-year growth: +32% (2020-2024). Mitigating measures litigation increasing post-ADAAA (2008).
Estimated 5,000-7,000 annual complaints across all sectors. Education: 60%, Healthcare: 20%, Social Services: 15%. Common violations include failure to provide reasonable accommodations and discriminatory discipline.
A comprehensive quantum-resistant cryptographic stack designed for genomic-phenotypic risk scoring systems with full regulatory compliance for HIPAA, GINA, ADA, and SSA requirements.
Ready for USPTO submission
Title: Quantum-Secure Genomic-Phenotypic Risk Scoring System
Inventor: Caustin Lee McLaughlin
Claims: 28 independent claims covering PQC integration, PRS calculation, and regulatory mapping
Protocol development phase
ID: GPRS-CINP-01
Title: Genomic-Phenotypic Risk Scoring in Neurocognitive Impairment Prediction
Status: Protocol development phase
| Component | Algorithm | Strength | Use Case |
|---|---|---|---|
| {item.usage} | {item.component} | {item.strength}-bit | {item.usage === 'KEM' && 'Key encapsulation, resistant to Shor\'s algorithm'} {item.usage === 'Signature' && 'Long-term evidence authentication'} {item.usage === 'Hash' && 'Merkle tree construction, semantic traces'} {item.usage === 'Symmetric' && 'Data encryption for transmission'} |
Status: Ready for USPTO submission
Inventor: Caustin Lee McLaughlin
28 independent claims covering PQC cryptography integration, research-weighted PRS calculation, SSA regulatory mapping, Merkle tree verification, and zero-knowledge proof generation.
Status: Protocol development phase
Primary Endpoints:
Status: Class III (PMA pathway)
Compliance with 21 CFR Part 11 and IEC 62304 for medical device software lifecycle processes.
Cybersecurity documentation aligned with FDA 2023 guidance.
Comprehensive litigation and regulatory compliance data
GPRS-Secure++ framework and federal legal requirements
Python implementation of genomic pipeline with 6 phases including PubMed research, LD-aware SNP generation, PRS calculation, privacy-preserving synthesis, SSA mapping, and cryptographic evidence packaging.